ITRM ITERUM THERAPEUTICS PLC Management Changes 8-K Filing 2025 - Director Resignation Iterum Therapeutics plc notified Nasdaq that it is not in compliance with listing rules due to a vacancy on its audit committee after Ronald Hunt's resignation as Chairman and director, effective February 14, 2025.Get access to all SEC 8-K filings of the ITERUM THERAPEUTICS PLC